☆Birchview Capital, LP
Quality Q
0.194
AUM ($M)
214
Positions
72
Turnover
0.24
Top-10 wt
60%
Herfindahl
0.085
History (qtrs)
12
Excess Return
—
AI Eval Run AI Eval
Holdings · 87 positions · portfolio value $214M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆KLAC funds › | KLA CORPORATION | ADD | — | 25.2% | +8.5% | 53.8 | 178,471 | +158,588 | 5 | — |
| ☆BMY funds › | BRISTOL-MYERS SQUIBB CO | TRIM | — | 8.0% | -2.6% | 17.1 | 297,243 | -9,025 | 7 | — |
| ☆LRCX funds › | LAM RESEARCH CORPORATION | TRIM | — | 7.1% | +2.7% | 15.2 | 35,000 | -1,000 | 3 | — |
| ☆NTLA funds › | INTELLIA THERAPEUTICS INC | TRIM | — | 3.2% | -0.1% | 6.8 | 385,900 | -59,500 | 5 | — |
| ☆SLDB funds › | SOLID BIOSCIENCES INC | ADD | — | 3.1% | +0.5% | 6.7 | 666,196 | +40,216 | 6 | — |
| ☆CUSIP:09075X108 funds › | BIODESIX INC | HOLD | — | 3.0% | +0.7% | 6.5 | 286,804 | +0 | 7 | — |
| ☆STOK funds › | STOKE THERAPEUTICS INC | TRIM | — | 2.7% | -1.2% | 5.8 | 178,110 | -31,890 | 7 | — |
| ☆OVV funds › | OVINTIV INC | HOLD | — | 2.6% | -1.0% | 5.7 | 107,500 | +0 | 7 | — |
| ☆NKTR funds › | NEKTAR THERAPEUTICS | ADD | — | 2.6% | +1.4% | 5.7 | 81,000 | +50,000 | 4 | — |
| ☆CORT funds › | CORCEPT THERAPEUTICS INC | ADD | — | 2.3% | +1.2% | 5.0 | 57,200 | +10,000 | 7 | — |
| ☆NBIX funds › | NEUROCRINE BIOSCIENCES INC | HOLD | — | 2.1% | +0.1% | 4.6 | 27,190 | +0 | 7 | — |
| ☆PRTA funds › | PROTHENA CORP PLC | HOLD | — | 2.1% | -0.4% | 4.4 | 449,019 | +0 | 7 | — |
| ☆ACAD funds › | ACADIA PHARMACEUTICALS INC | HOLD | — | 2.0% | -0.1% | 4.3 | 171,000 | +0 | 7 | — |
| ☆PTGX funds › | PROTAGONIST THERAPEUTICS INC | ADD | — | 2.0% | -0.1% | 4.3 | 35,018 | +18 | 7 | — |
| ☆CMPX funds › | COMPASS THERAPEUTICS INC | ADD | — | 1.7% | -2.7% | 3.7 | 1,675,000 | +209,133 | 4 | — |
| ☆RLMD funds › | RELMADA THERAPEUTICS INC | TRIM | — | 1.3% | -0.3% | 2.8 | 408,100 | -1,287 | 2 | — |
| ☆ALKS funds › | ALKERMES PLC | HOLD | — | 1.2% | +0.2% | 2.6 | 50,000 | +0 | 7 | — |
| ☆HALO funds › | HALOZYME THERAPEUTICS INC | ADD | — | 1.2% | +0.8% | 2.6 | 33,251 | +23,151 | 7 | — |
| ☆CLDX funds › | CELLDEX THERAPEUTICS INC | TRIM | — | 1.2% | -0.0% | 2.6 | 69,900 | -195 | 2 | — |
| ☆CYTK funds › | CYTOKINETICS INC | HOLD | — | 1.2% | +0.1% | 2.6 | 30,000 | +0 | 7 | — |
| ☆OLMA funds › | OLEMA PHARMACEUTICALS INC | TRIM | — | 1.2% | -0.7% | 2.5 | 199,000 | -20,000 | 5 | — |
| ☆VERA funds › | VERA THERAPEUTICS INC | ADD | — | 1.2% | +0.2% | 2.5 | 57,758 | +13,758 | 3 | — |
| ☆UTHR funds › | UNITED THERAPEUTICS CORP | ADD | — | 1.1% | -0.4% | 2.4 | 4,506 | +6 | 7 | — |
| ☆ZBIO funds › | ZENAS BIOPHARMA INC | ADD | — | 1.1% | +0.3% | 2.4 | 93,601 | +23,601 | 2 | — |
| ☆QURE funds › | UNIQURE NV | TRIM | — | 1.1% | +0.2% | 2.3 | 50,697 | -50,000 | 7 | — |
| ☆PACB funds › | PACIFIC BIOSCIENCES OF CALIFORNIA INC | TRIM | — | 1.1% | -0.1% | 2.3 | 1,350,000 | -150,000 | 5 | — |
| ☆ABVX funds › | ABIVAX SA | NEW | — | 1.1% | +1.1% | 2.3 | 17,000 | +17,000 | 1 | — |
| ☆VIR funds › | VIR BIOTECHNOLOGY INC | NEW | — | 1.0% | +1.0% | 2.2 | 220,000 | +220,000 | 1 | — |
| ☆BIIB funds › | BIOGEN INC | ADD | — | 0.9% | +0.4% | 1.9 | 9,000 | +4,000 | 2 | — |
| ☆EQT funds › | EQT CORPORATION | HOLD | — | 0.9% | -0.4% | 1.8 | 34,619 | +0 | 7 | — |
| ☆BIOA funds › | BIOAGE LABS INC | NEW | — | 0.8% | +0.8% | 1.7 | 69,000 | +69,000 | 1 | — |
| ☆TVTX funds › | TRAVERE THERAPEUTICS INC | TRIM | — | 0.8% | +0.3% | 1.6 | 29,000 | -200 | 7 | — |
| ☆CUSIP:74838J101 funds › | QUIDELORTHO CORP | ADD | — | 0.7% | -0.0% | 1.6 | 89,377 | +6,829 | 7 | — |
| ☆AXSM funds › | AXSOME THERAPEUTICS INC | HOLD | — | 0.7% | +0.1% | 1.5 | 6,000 | +0 | 7 | — |
| ☆FHTX funds › | FOGHORN THERAPEUTICS INC | ADD | — | 0.6% | -0.1% | 1.4 | 281,937 | +207 | 7 | — |
| ☆BCYC funds › | BICYCLE THERAPEUTICS PLC | TRIM | — | 0.6% | -0.6% | 1.3 | 313,616 | -149,983 | 4 | — |
| ☆GPCR funds › | STRUCTURE THERAPEUTICS INC | TRIM | — | 0.6% | -2.1% | 1.3 | 24,000 | -76,000 | 5 | — |
| ☆XENE funds › | XENON PHARMACEUTICALS INC | ADD | — | 0.6% | -0.1% | 1.3 | 21,032 | +32 | 7 | — |
| ☆NVO funds › | NOVO NORDISK A/S | NEW | — | 0.5% | +0.5% | 1.2 | 24,000 | +24,000 | 1 | — |
| ☆FCX funds › | FREEPORT-MCMORAN CL-B | TRIM | — | 0.5% | -0.1% | 1.1 | 18,035 | -5 | 5 | — |
| ☆IMNM funds › | IMMUNOME INC | HOLD | — | 0.5% | -0.1% | 1.1 | 50,000 | +0 | 5 | — |
| ☆PHVS funds › | PHARVARIS N V | HOLD | — | 0.5% | +0.0% | 1.0 | 29,847 | +0 | 4 | — |
| ☆HROW funds › | HARROW HEALTH INC | HOLD | — | 0.5% | -0.0% | 1.0 | 24,000 | +0 | 7 | — |
| ☆ADAG funds › | ADAGENE INC | NEW | — | 0.5% | +0.5% | 1.0 | 240,000 | +240,000 | 1 | — |
| ☆DFTX funds › | DEFINIUM THERAPEUTICS INC | NEW | — | 0.4% | +0.4% | 0.9 | 20,000 | +20,000 | 1 | — |
| ☆SLN funds › | SILENCE THERAPEUTICS PLC | NEW | — | 0.4% | +0.4% | 0.8 | 71,218 | +71,218 | 1 | — |
| ☆BBIO funds › | BRIDGEBIO PHARMA INC | ADD | — | 0.3% | -0.1% | 0.7 | 8,741 | +53 | 5 | — |
| ☆FDMT funds › | 4D MOLECULAR THERAPEUTICS INC | NEW | — | 0.3% | +0.3% | 0.6 | 48,505 | +48,505 | 1 | — |
| ☆URGN funds › | UROGEN PHARMA LTD | NEW | — | 0.3% | +0.3% | 0.6 | 16,487 | +16,487 | 1 | — |
| ☆PHAT funds › | PHATHOM PHARMACEUTICALS INC | TRIM | — | 0.3% | -1.0% | 0.6 | 55,000 | -140,000 | 5 | — |
| ☆CAMP funds › | CAMP4 THERAPEUTICS CORP | NEW | — | 0.2% | +0.2% | 0.5 | 120,000 | +120,000 | 1 | — |
| ☆SVRA funds › | SAVARA INC | NEW | — | 0.2% | +0.2% | 0.5 | 80,000 | +80,000 | 1 | — |
| ☆CADL funds › | CANDEL THERAPEUTICS INC | TRIM | — | 0.2% | +0.1% | 0.5 | 47,756 | -12,244 | 7 | — |
| ☆ALT funds › | ALTIMMUNE INC | NEW | — | 0.2% | +0.2% | 0.5 | 152,681 | +152,681 | 1 | — |
| ☆CMPS funds › | COMPASS PATHWAYS LTD | TRIM | — | 0.2% | -1.0% | 0.4 | 30,000 | -345,000 | 2 | — |
| ☆CUSIP:48576U106 funds › | KARYOPHARM THERAPEUTICS INC | TRIM | — | 0.2% | -0.1% | 0.4 | 42,952 | -41,000 | 2 | — |
| ☆CGEM funds › | CULLINAN THERAPEUTICS INC | HOLD | — | 0.2% | +0.0% | 0.4 | 20,000 | +0 | 7 | — |
| ☆TRIN funds › | TRINITY CAP INC | HOLD | — | 0.2% | -0.0% | 0.4 | 20,000 | +0 | 3 | — |
| ☆CAPR funds › | CAPRICOR THERAPEUTICS INC | NEW | — | 0.2% | +0.2% | 0.3 | 14,352 | +14,352 | 1 | — |
| ☆CSTL funds › | CASTLE BIOSCIENCES INC | ADD | — | 0.1% | -0.0% | 0.3 | 12,984 | +84 | 7 | — |
| ☆IVVD funds › | INVIVYD INC | NEW | — | 0.1% | +0.1% | 0.3 | 342,275 | +342,275 | 1 | — |
| ☆GRCE funds › | GRACE THERAPEUTICS INC | ADD | — | 0.1% | -0.0% | 0.3 | 120,000 | +70,000 | 2 | — |
| ☆KBDC funds › | KAYNE ANDERSON BDC INC | HOLD | — | 0.1% | -0.0% | 0.3 | 20,000 | +0 | 3 | — |
| ☆VYGR funds › | VOYAGER THERAPEUTICS INC | ADD | — | 0.1% | -0.0% | 0.3 | 75,147 | +229 | 4 | — |
| ☆LUNG funds › | PULMONX CORP | TRIM | — | 0.1% | -0.1% | 0.3 | 200,543 | -49,678 | 3 | — |
| ☆OCUL funds › | OCULAR THERAPEUTIX INC | TRIM | — | 0.1% | -1.4% | 0.2 | 20,655 | -299,345 | 2 | — |
| ☆KYNB funds › | KYNTRA BIO INC | HOLD | — | 0.1% | -0.0% | 0.2 | 22,566 | +0 | 2 | — |
| ☆ELUT funds › | ELUTIA INC | HOLD | — | 0.1% | -0.0% | 0.2 | 165,094 | +0 | 7 | — |
| ☆QNRX funds › | QUOIN PHARMACEUTICALS LTD | HOLD | — | 0.0% | -0.0% | 0.1 | 20,000 | +0 | 2 | — |
| ☆CUSIP:53630X203 funds › | LIPOCINE INC | TRIM | — | 0.0% | -0.5% | 0.0 | 16,712 | -95,074 | 2 | — |
| ☆DCGO funds › | DOCGO INC | TRIM | — | 0.0% | -0.0% | 0.0 | 39,062 | -511 | 7 | — |
| ☆GOSS funds › | GOSSAMER BIO INC | HOLD | — | 0.0% | -0.0% | 0.0 | 18,176 | +0 | 7 | — |
| ☆PHR funds › | PHREESIA INC | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -14,300 | 0 | — |
| ☆APGE funds › | APOGEE THERAPEUTICS INC | EXIT | — | 0.0% | -0.4% | 0.0 | 0 | -9,000 | 0 | — |
| ☆CUSIP:483497103 funds › | KALVISTA PHARMACEUTICALS INC | EXIT | — | 0.0% | -0.7% | 0.0 | 0 | -57,000 | 0 | — |
| ☆CUSIP:690145107 funds › | OUTSET MEDICAL INC | EXIT | — | 0.0% | -0.2% | 0.0 | 0 | -98,882 | 0 | — |
| ☆IDYA funds › | IDEAYA BIOSCIENCES INC | EXIT | — | 0.0% | -0.3% | 0.0 | 0 | -16,860 | 0 | — |
| ☆VSTM funds › | VERASTEM INC | EXIT | — | 0.0% | -0.5% | 0.0 | 0 | -150,000 | 0 | — |
| ☆RCKT funds › | ROCKET PHARMACEUTICALS INC | EXIT | — | 0.0% | -0.3% | 0.0 | 0 | -127,025 | 0 | — |
| ☆CUSIP:03753U106 funds › | APELLIS PHARMACEUTICALS INC | EXIT | — | 0.0% | -0.3% | 0.0 | 0 | -14,000 | 0 | — |
| ☆RCUS funds › | ARCUS BIOSCIENCES INC | EXIT | — | 0.0% | -0.3% | 0.0 | 0 | -25,889 | 0 | — |
| ☆VRDN funds › | VIRIDIAN THERAPEUTICS INC | EXIT | — | 0.0% | -0.2% | 0.0 | 0 | -20,100 | 0 | — |
| ☆NVCR funds › | NOVOCURE LTD | EXIT | — | 0.0% | -1.3% | 0.0 | 0 | -202,330 | 0 | — |
| ☆CUSIP:29286M105 funds › | ENGENE HOLDINGS INC | EXIT | — | 0.0% | -1.0% | 0.0 | 0 | -250,000 | 0 | — |
| ☆RGNX funds › | REGENXBIO INC | EXIT | — | 0.0% | -0.3% | 0.0 | 0 | -66,270 | 0 | — |
| ☆RARE funds › | ULTRAGENYX PHARMACEUTICAL INC | EXIT | — | 0.0% | -0.7% | 0.0 | 0 | -62,000 | 0 | — |
| ☆ZNTL funds › | ZENTALIS PHARMACEUTICALS INC | EXIT | — | 0.0% | -0.0% | 0.0 | 0 | -17,503 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 214 | 72 | 0.24 | 60% | 0.085 | 0.195 | — | in |
| 2026Q1 | 176 | 73 | 0.20 | 55% | 0.054 | 0.203 | — | in |
| 2025Q4 | 171 | 68 | 0.25 | 55% | 0.051 | 0.117 | — | in |
| 2025Q3 | 132 | 69 | 0.20 | 56% | 0.058 | 0.152 | — | in |
| 2025Q2 | 101 | 71 | 0.31 | 57% | 0.058 | 0.070 | — | in |
| 2025Q1 | 115 | 68 | 0.13 | 66% | 0.147 | 0.370 | — | in |
| 2024Q4 | 123 | 68 | 0.09 | 65% | 0.118 | 0.416 | — | in |
| 2024Q3 | 115 | 61 | 0.15 | 67% | 0.117 | 0.231 | — | in |
| 2024Q2 | 108 | 60 | 0.14 | 68% | 0.096 | 0.275 | — | in |
| 2024Q1 | 123 | 59 | 0.13 | 68% | 0.119 | 0.348 | — | in |
| 2023Q4 | 128 | 58 | 0.14 | 70% | 0.106 | 0.359 | — | entered |
| 2023Q3 | 118 | 51 | 0.00 | 75% | 0.149 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status